Cargando…

Motor cortical excitability predicts cognitive phenotypes in amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are well-recognised as an extended disease spectrum. This study hypothesised that cortical hyperexcitability, an early pathophysiological abnormality in ALS, would distinguish cognitive phenotypes, as a surrogate marker of patholo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agarwal, Smriti, Highton-Williamson, Elizabeth, Caga, Jashelle, Howells, James, Dharmadasa, Thanuja, Matamala, José M., Ma, Yan, Shibuya, Kazumoto, Hodges, John R., Ahmed, Rebekah M., Vucic, Steve, Kiernan, Matthew C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838179/ https://www.ncbi.nlm.nih.gov/pubmed/33500476 http://dx.doi.org/10.1038/s41598-021-81612-x

Ejemplares similares

Cortical inexcitability defines an adverse clinical profile in amyotrophic lateral sclerosis
por: Dharmadasa, T., et al.
Publicado: (2020)

Functional Biomarkers for Amyotrophic Lateral Sclerosis
por: Huynh, William, et al.
Publicado: (2019)

Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia
por: Ahmed, Rebekah M., et al.
Publicado: (2019)

Cortical Excitability across the ALS Clinical Motor Phenotypes
por: Dharmadasa, Thanuja
Publicado: (2021)

Cortical Dysfunction Underlies the Development of the Split-Hand in Amyotrophic Lateral Sclerosis
por: Menon, Parvathi, et al.
Publicado: (2014)

Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum
por: Tse, Nga Yan, et al.
Publicado: (2022)

Utility of threshold tracking transcranial magnetic stimulation in ALS
por: Vucic, Steve, et al.
Publicado: (2018)

Schizotypal traits across the amyotrophic lateral sclerosis–frontotemporal dementia spectrum: pathomechanistic insights
por: Tse, Nga Yan, et al.
Publicado: (2022)

Improving clinical trial outcomes in amyotrophic lateral sclerosis
por: Kiernan, Matthew C., et al.
Publicado: (2020)

Tackling clinical heterogeneity across the amyotrophic lateral sclerosis–frontotemporal dementia spectrum using a transdiagnostic approach
por: Ahmed, Rebekah M, et al.
Publicado: (2021)

Regional motor cortex dysfunction in amyotrophic lateral sclerosis
por: Menon, Parvathi, et al.
Publicado: (2019)

The Puzzling Case of Hyperexcitability in Amyotrophic Lateral Sclerosis
por: Bae, Jong Seok, et al.
Publicado: (2013)

Neuronal Hyperexcitability and Free Radical Toxicity in Amyotrophic Lateral Sclerosis: Established and Future Targets
por: Shibuya, Kazumoto, et al.
Publicado: (2022)

Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights
por: Vucic, Steve, et al.
Publicado: (2013)

Factors That Influence Non-Motor Impairment Across the ALS-FTD Spectrum: Impact of Phenotype, Sex, Age, Onset and Disease Stage
por: Devenney, Emma M., et al.
Publicado: (2021)

Quantifying Disease Progression in Amyotrophic Lateral Sclerosis
por: Simon, Neil G, et al.
Publicado: (2014)

Illness Cognitions in ALS: New Insights Into Clinical Management of Behavioural Symptoms
por: Caga, Jashelle, et al.
Publicado: (2021)

Limited value of serum neurofilament light chain in diagnosing amyotrophic lateral sclerosis
por: Davies, Jennifer C, et al.
Publicado: (2023)

Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis
por: Gao, Jiali, et al.
Publicado: (2022)

Dissociation of Structural and Functional Integrities of the Motor System in Amyotrophic Lateral Sclerosis and Behavioral-Variant Frontotemporal Dementia
por: Bae, Jong Seok, et al.
Publicado: (2016)

Brainstem Correlates of Pathological Laughter and Crying Frequency in ALS
por: Tu, Sicong, et al.
Publicado: (2021)

Neurophysiological Mechanisms Underlying Cortical Hyper-Excitability in Amyotrophic Lateral Sclerosis: A Review
por: Pradhan, Jonu, et al.
Publicado: (2021)

Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS‐FTD spectrum
por: Devenney, Emma M., et al.
Publicado: (2021)

Axonal Dysfunction Precedes Motor Neuronal Death in Amyotrophic Lateral Sclerosis
por: Iwai, Yuta, et al.
Publicado: (2016)

The Cortical Signature of Amyotrophic Lateral Sclerosis
por: Agosta, Federica, et al.
Publicado: (2012)

Motor cortical function and the precision grip
por: Geevasinga, Nimeshan, et al.
Publicado: (2014)

Flecainide in Amyotrophic Lateral Sclerosis as a Neuroprotective Strategy (FANS): A Randomized Placebo-Controlled Trial
por: Park, Susanna B., et al.
Publicado: (2015)

Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
por: Tan, Rachel H., et al.
Publicado: (2023)

Development of patient decision support tools for motor neuron disease using stakeholder consultation: a study protocol
por: Hogden, Anne, et al.
Publicado: (2016)

Cerebellar Integrity in the Amyotrophic Lateral Sclerosis - Frontotemporal Dementia Continuum
por: Tan, Rachel H., et al.
Publicado: (2014)

Grey and White Matter Changes across the Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Continuum
por: Lillo, Patricia, et al.
Publicado: (2012)

Reduced Excitability and Increased Neurite Complexity of Cortical Interneurons in a Familial Mouse Model of Amyotrophic Lateral Sclerosis
por: Clark, Rosemary M., et al.
Publicado: (2018)

Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study): Study protocol clinical trial (SPIRIT Compliant)
por: Vucic, Steve, et al.
Publicado: (2020)

Fasciculation intensity and limb dominance in amyotrophic lateral sclerosis: a muscle ultrasonographic study
por: Suzuki, Yo-ichi, et al.
Publicado: (2022)

Utility of Transcranial Magnetic Simulation in Studying Upper Motor Neuron Dysfunction in Amyotrophic Lateral Sclerosis
por: Geevasinga, Nimeshan, et al.
Publicado: (2021)

Thalamic and Cerebellar Regional Involvement across the ALS–FTD Spectrum and the Effect of C9orf72
por: Bocchetta, Martina, et al.
Publicado: (2022)

Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis
por: Phan, Katherine, et al.
Publicado: (2022)

Brain Stimulation as a Therapeutic Tool in Amyotrophic Lateral Sclerosis: Current Status and Interaction With Mechanisms of Altered Cortical Excitability
por: Ranieri, Federico, et al.
Publicado: (2021)

Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
por: Katzeff, Jared S., et al.
Publicado: (2022)

Cortical Thinning and Clinical Heterogeneity in Amyotrophic Lateral Sclerosis
por: Mezzapesa, Domenico Maria, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5b742c0954dmk91n1m8e21et42